Pharma giants including Novartis collaborate on COVID-19 therapiesA consortium of life sciences companies including pharma giants such as Novartis and Johnson & Johnson, are to Share XPharma giants including Novartis collaborate on COVID-19 therapieshttps://pharmaphorum.com/news/collaborate-covid19-therapies/
Gilead rescinds orphan status request for COVID-19 drugGilead has rescinded its request for orphan status for its potential COVID-19 antiviral remdesivir amid a furore over Share XGilead rescinds orphan status request for COVID-19 drughttps://pharmaphorum.com/news/gilead-rescinds-orphan-status-request-for-covid-19-drug/
Vaccines trials in the COVID-19 era and tech’s role in speeding studiesOverview The COVID-19 outbreak has exposed the challenges pharmaceutical companies face as they race to develop a coronavirus Share XVaccines trials in the COVID-19 era and tech’s role in speeding studieshttps://pharmaphorum.com/webinars/live-webinar/vaccines-trials-covid-19-coronavirus/
AZ adds gene silencing tech to pipeline with Silence Therapeutics dealAstraZeneca has announced a collaboration with UK biotech Silence Therapeutics to develop gene silencing drugs for cardiovascular, renal, Share XAZ adds gene silencing tech to pipeline with Silence Therapeutics dealhttps://pharmaphorum.com/news/az-adds-gene-silencing-tech-to-pipeline-with-silence-therapeutics-deal/
Celltrion to develop coronavirus antibody and fast testSouth Korea’s Celltrion has joined the many pharma companies fighting the COVID-19 coronavirus outbreak, saying it is working Share XCelltrion to develop coronavirus antibody and fast testhttps://pharmaphorum.com/news/celltrion-antibody-and-fast-test/
Novartis publishes long-term data from SMA gene therapyNovartis has produced data demonstrating its Zolgensma gene therapy produces long term benefits in the rare muscle wasting Share XNovartis publishes long-term data from SMA gene therapyhttps://pharmaphorum.com/news/novartis-publishes-long-term-data-from-sma-gene-therapy/
Oxford University prepares for coronavirus vaccine trialScientists from the University of Oxford say they have identified a potential vaccine for the SARS-CoV-2 coronavirus that Share XOxford University prepares for coronavirus vaccine trialhttps://pharmaphorum.com/news/oxford-university-prepares-for-coronavirus-vaccine-trial/
Lilly, Galapagos suspend trials as COVID-19 hits health systemsEli Lilly has said it will suspend most clinical trials for the time being in light of the Share XLilly, Galapagos suspend trials as COVID-19 hits health systemshttps://pharmaphorum.com/news/lilly-galapagos-suspend-trials-as-covid-19-hits-health-systems/
Gilead halts ‘compassionate use’ of potential coronavirus drugGilead has said it has stopped accepting “compassionate use” requests for its potential coronavirus antiviral remdesivir because it Share XGilead halts ‘compassionate use’ of potential coronavirus drughttps://pharmaphorum.com/news/gilead-halts-compassionate-use-of-potential-coronavirus-drug/
